Human Health Holdings Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Human Health Holdings hat ein Gesamteigenkapital von HK$766.7M und eine Gesamtverschuldung von HK$31.5M, wodurch sich der Verschuldungsgrad auf 4.1% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen HK$1.1B bzw. HK$289.7M. Human Health Holdings Das EBIT des Unternehmens beträgt HK$5.8M, so dass der Zinsdeckungsgrad 0.7 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von HK$489.6M.

Wichtige Informationen

4.1%

Verhältnis von Schulden zu Eigenkapital

HK$31.54m

Verschuldung

Zinsdeckungsgrad	-2.2x
Bargeld	HK$489.58m
Eigenkapital	HK$766.67m
Gesamtverbindlichkeiten	HK$289.71m
Gesamtvermögen	HK$1.06b

Jüngste Berichte zur Finanzlage

Recent updates

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

May 31

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Feb 15

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

Dec 25

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 1419Die kurzfristigen Aktiva des Unternehmens (HK$612.7M) übersteigen seine kurzfristigen Passiva (HK$220.0M).

Langfristige Verbindlichkeiten: 1419Die kurzfristigen Vermögenswerte des Unternehmens (HK$612.7M) übersteigen seine langfristigen Verbindlichkeiten (HK$87.4M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 1419 über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: 1419Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 0% auf 4.4% gestiegen.

Schuldendeckung: 1419Die Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (517.1%).

Zinsdeckung: 1419 mehr Zinsen einnimmt als er zahlt, so dass die Deckung der Zinszahlungen kein Problem darstellt.

Human Health Holdings Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

Recent updates

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen